register

News & Trends - Medical Technology

Implant revolutionising epilepsy seizure detection and forecasting

Health Industry Hub | May 3, 2021 |
[Total: 1    Average: 5/5]

MedTech News: An Australian medtech company signed a strategic collaboration to accelerate ultra-long term EEG monitoring so people who suffer from seizures have an advanced digital therapeutics product to detect and forecast their seizures.

Epiminder is evaluating its Minder ultra-long term EEG implant at St Vincent’s Hospital in Melbourne. These ultra-long term EEG recordings produce enormous data sets and require advanced algorithms and data curation to generate new insights into patient seizure patterns.

Leveraging Seer Medical’s advanced capabilities in cloud and app-based platforms to detect, report and forecast seizures and abnormal brain activity, will enable, for the first time, specialists in this field to better understand individual patients’ circumstances and medication.

University of Melbourne Professor Mark Cook, Chair of Medicine at St Vincent’s Hospital Melbourne, said “Many people with epilepsy do not achieve adequate control of their seizures. Many of these people live in persistent anxiety and everyday tasks like driving or cooking can become life-threatening. Seer Medical and Epiminder have very complementary technologies that, together, have the potential to dramatically improve epilepsy care.”

You may also like Data is the biggest challenge, and opportunity, for MedTech

Rohan Hoare, CEO of Epiminder said, “This agreement between Seer Medical and Epiminder is poised to accelerate the clinical insight of Minder EEG recordings and potentially add substantial value to our product offering.”

Dean Freestone, CEO of Seer Medical said “Bringing together the Minder EEG monitor and the Seer Cloud technology, patients will be able to gauge the likelihood of a seizure occurring via an app, bringing back control into people’s lives.”

Epilepsy affects 65 million people globally. Refractory epilepsy affects 30% to 40% of these patients, who cannot be adequately managed by drug therapy to remain seizure free.

Epiminder was launched in June 2018 to commercialise intellectual property created by a research team led by Professor Mark Cook, Neurologist at St Vincent’s Hospital, Melbourne and Chair of Medicine at the University of Melbourne; and Associate Professor Chris Williams from Bionics Institute.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Digital & Innovation

Healthcare Technology Digital Innovations - Genomics industry making headlines at HealthData21

Genomics industry making headlines at HealthData21

Health Industry Hub | May 13, 2021 |

Australia’s new genomics industry alliance Industry Genomics Network Alliance (InGeNA) will bring together representatives from the key sectors of diagnostics, […]

More


News & Trends - Medical Technology

MedTech News - B. Braun launches renal care centre in NSW and QLD

B. Braun launches renal care centres in NSW and QLD

Health Industry Hub | May 13, 2021 |

MedTech News: B. Braun, one of the world’s leading providers of medical devices, dialysis products and renal care services has […]

More


News & Trends - Pharmaceuticals

Pharma News - BMS immunotherapy combo approved in aggressive thoracic cancer

BMS immunotherapy combo approved in aggressive thoracic cancer

Health Industry Hub | May 13, 2021 |

Pharma News: Bristol-Myers Squibb (BMS) welcomed the Therapeutics Goods Administration (TGA) registration of its immunotherapy combination drugs for the first-line […]

More


News & Trends - Pharmaceuticals

Pharma News - GSK bridges the skills gap between academia and pharma industry

GSK bridges the skills gap between academia and pharma industry

Health Industry Hub | May 13, 2021 |

Pharma News: Six PhD graduates have recently traded in their lab coats for laptops after landing a place in a […]

More